Epidemiological, Observational, Post Marketing Study of the Genetic Stability of GSK Biologicals' Rotavirus Vaccine (Rotarix) in Children <5 Years of Age Diagnosed With Severe Gastroenteritis, in Belgium
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2016
At a glance
- Drugs RIX 4414 (Primary)
- Indications Gastroenteritis; Rotavirus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 20 Jul 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Mar 2012 Planned number of patients changed from 164 to 50 as reported by ClinicalTrials.gov.